"Cooperative benefit for the combination of rapamycin and imatinib in tuberous sclerosis complex neoplasia" by Baskaran Govindarajan

Selected Works of Emir Veledar

Follow Contact

Article

Cooperative benefit for the combination of rapamycin and imatinib in tuberous sclerosis complex neoplasia

Vascular Cell (2012)

Baskaran Govindarajan, Emory University
Laura Willoughby, Eppley Institute for Research in Cancer and Allied Diseases
Hamid Band, Eppley Institute for Research in Cancer and Allied Diseases
Adam S. Curatolo, Boston Children's Hospital
Emir Veledar, Emory University
Suephy Chen, Emory University
Michael Y. Bonner, Emory University
Martin Garrido Abel, Emory University
Marsha A. Moses, Boston Children's Hospital
Jack L. Arbiser, Emory University

Link

Disciplines

Medicine and Health Sciences and
Pathology

Publication Date

January 1, 2012

DOI

10.1186/2045-824X-4-11

Citation Information

Baskaran Govindarajan, Laura Willoughby, Hamid Band, Adam S. Curatolo, et al.. "Cooperative benefit for the combination of rapamycin and imatinib in tuberous sclerosis complex neoplasia" Vascular Cell Vol. 4 Iss. 1 (2012) p. 11 - 11
Available at: http://works.bepress.com/emir-veledar/326/